Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,679
+$27,201 QoQ
Shares Held
21,773
-44.2% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 147 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GROUP ONE TRADING LLC holds $113,695,832 across 200 Biotechnology names. CCCC ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
203,915 | $14,280,167 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
261,443 | $10,198,891 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
272,609 | $6,564,424 | |
| 4 | ABSI |
Absci Corp
|
524,747 | $6,081,817 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
151,994 | $5,640,497 | |
| 6 | NKTR |
Nektar Therapeutics
|
70,371 | $4,912,599 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
85,040 | $4,638,081 | |
| 8 | ABVX |
Abivax S.A.
|
29,767 | $3,966,750 |
All Filings in CCCC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,679 | 21,773 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $74,478 | 38,994 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $27,599 | 12,432 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21 | 15 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $118,378 | 32,883 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $8,015 | 1,735 | Shares | Sole | 2024-08-14 | |
| 2022-03-31 | $109,170 | 4,500 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $16,100 | 500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,404 | 300 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||